New York, December 20, 2023 – Clinical-stage biotechnology company, Lipella Pharmaceuticals (Nasdaq: LIPO) is celebrating a year of strategic accomplishments on its first anniversary as a public company. Lipella is advancing three clinical indications and has been granted two Orphan Drug Designations by the US Food and Drug Administration (FDA). Lipella Pharmaceuticals Inc Today, the company announced it has … Continue reading “PRISM MarketView: Biotech In Motion – Lipella Pharmaceuticals Celebrates Year of Success”
Breaking News
Spooz, Inc. (SPZI) Completes Primary Acquisitions and Change of Control
Spooz Acquired Key JP Energy Assets; Vests Control to John K. Park Clearwater, FL., December…
Buy Now, Pay Later: Affirm Shares Jump on News of Walmart Partnership
New York, December 20, 2023 – Shares in payment network company, Affirm Holdings (Nasdaq: AFRM), jumped more…
Lipella Pharmaceuticals Marks Successful First Year with Strategic Progress and Key Milestones Accomplished
–Lipella Granted Two Orphan Drug Designations by FDA- Pittsburgh, PA, December 20, 2023 – Lipella…
SinglePoint Announces Closing of $4 Million Public Offering, Uplisting to Cboe Global Markets and Reverse Stock Split
Phoenix, AZ, December 19, 2023 – SinglePoint Inc. (Cboe: SING) (“SinglePoint” or the “Company”), a diversified…
NRx Pharmaceuticals Secures IND for Urinary Tract Infection Treatment
New York, December 19, 2023 – NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) has been granted FDA clearance for its…
PPJ Healthcare Enterprises, Inc. signed new Billing Accounts
TAMPA, FLORIDA, December 19, 2023 – PPJ Healthcare Enterprises Inc. (OTC Pink: PPJE) has announced…
BioStem Technologies Appoints Executive Leader Patrick Daly to Board of Directors
POMPANO BEACH, FLORIDA, December 19, 2023 – BioStem Technologies Inc. (OTC: BSEM), a leading regenerative…
PRISM Analysis: Why Did Battalion Oil Shares Soar on Friday?
NEW YORK, NY, December 18, 2023 – Shares in Battalion Oil Corporation (NYSE American: BATL) surged more…
MindMed Advances Treatment for Generalized Anxiety Disorder
NEW YORK, NY, December 18, 2023 – Biopharmaceutical company, Mind Medicine (Nasdaq: MNMD) has announced positive results from…
SinglePoint Rings the Opening Bell at Cboe Global Markets Exchange
Phoenix, AZ, December 18, 2023 – SinglePoint Inc. (Cboe: SING) (“SinglePoint” or the “Company”), a renewable…
PRISM AdTech & Media Company Spotlight: Creative Realities Illuminates the Future of Experiential Design
In the fast-paced landscape of experiential design and technology, Creative Realities Inc. seamlessly integrates the…
PRISM MediaWire – Weekly Press Resume – Dec. 11 to Dec. 15, 2023
New York, December 15, 2023 PRISM MediaWire – Weekly Press Resume Dec. 11 to Dec.…
“Exceptional Result”: NeuroSense Therapeutics Reports New Positive Data from ALS Trial
NEW YORK, NY, December 15, 2023 – NeuroSense Therapeutics Ltd. (Nasdaq: NRSN) has reported additional positive efficacy data from its…